Records containing: Non-Alcoholic Fatty Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals - Extended Validation.
-
CLINICAL_TRIALS study record update · 2026-04-16CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
-
CLINICAL_TRIALS study record update · 2026-04-15Semaglutide, 2.4mg, Once Weekly: Effects on Beta-cell Preservation and Reduction of Intrahepatic Triglyceride Content in Obese Youth With Prediabetes (IGT)/Early Type 2 Diabetes (T2D) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
-
CLINICAL_TRIALS study record update · 2026-04-14The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-04-13Evaluating the Repeatability and Reproducibility of FibroScan Generations
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1, Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial of LY3885125 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Ascending Dose in Participants With Dyslipidemia and Repeat-Doses in Participants With NAFLD
-
CLINICAL_TRIALS study record update · 2026-04-09Human Models of Selective Insulin Resistance: Diazoxide, Part I
-
CLINICAL_TRIALS study record update · 2026-04-09Human Models of Selective Insulin Resistance: Alpelisib, Part I
-
CLINICAL_TRIALS study record update · 2026-04-03A Case-Control, Observational, Proof of Mechanism Study to Define Microbiome-Mediated Gut Dysfunction Across the Spectrum of Non-Alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-04-01Field-Cycling Imaging Effectiveness in Non-alcoholic Fatty Liver Disease Stratification
-
CLINICAL_TRIALS study record update · 2026-03-25EndoNAFLD: Evaluation of the Relationship Between Fatty Liver Disease and Endothelial Damage in Patients at High Risk of Cardiovascular Disease
-
CLINICAL_TRIALS study record update · 2026-03-23Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis
-
CLINICAL_TRIALS study record update · 2026-03-20Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
-
CLINICAL_TRIALS study record update · 2026-03-13Prevention of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanic Children
-
CLINICAL_TRIALS study record update · 2026-03-11Feasibility Study for Quantifying Fatty Liver Using Thermo-acoustic Imaging
-
CLINICAL_TRIALS study record update · 2026-03-02Endoscopic Ultrasound Shear Wave Elastography: A Novel Tool for Fibrosis Screening in Patient With Elevated Body Mass Index and Suspected Non-Alcoholic Fatty Liver Disease or Steatohepatitis
-
CLINICAL_TRIALS study record update · 2026-02-27Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-02-24Prospective Sample Collection Study for Discovery and Evaluation of Novel Blood Based Biomarkers for Assessment of Hepatic Fibrosis
-
CLINICAL_TRIALS study record update · 2026-02-20Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in Patients With Nonalcoholic Hepatitis
-
CLINICAL_TRIALS study record update · 2026-02-18CoMOrbidities Resolution After Mini-GAstric Bypass Surgery for Morbid Obesity and Change in BOdy Composition: A Prospective Cohort Study (MOGAMBO Study)
-
CLINICAL_TRIALS study record update · 2026-02-12Evaluation of XTYW007 in Healthy Subjects and Healthy Subjects With Elevated LDL-C:A Randomized, Double-Blind, Single-Center Phase I/IIa Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect Following Single and Multiple Doses
-
CLINICAL_TRIALS study record update · 2026-02-12"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
-
CLINICAL_TRIALS study record update · 2026-02-09Integrated Diagnostics for Early Diagnosis of Liver Disease
-
CLINICAL_TRIALS study record update · 2026-02-06Human Models of Selective Insulin Resistance: Pancreatic Clamp
-
CLINICAL_TRIALS study record update · 2026-02-05A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of MN-001 in Patients Diagnosed With Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia